scholarly journals How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study

2015 ◽  
Vol 18 (4) ◽  
pp. 216-224 ◽  
Author(s):  
Jenny E. Ostergren ◽  
Michele C. Gornick ◽  
Deanna Alexis Carere ◽  
Sarah S. Kalia ◽  
Wendy R. Uhlmann ◽  
...  
Keyword(s):  
Genetic Test ◽  
Genomic Testing ◽  
Test Results ◽  
Personal Genomics ◽  
Personal Genomic ◽  
Personal Genomic Testing ◽  
Direct To Consumer ◽  
Genetic Test Results ◽  
The Impact

scholarly journals Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study

2016 ◽  
Vol 19 (5) ◽  
pp. 537-545 ◽  
Author(s):  
Deanna Alexis Carere ◽  
◽  
Tyler J. VanderWeele ◽  
Jason L. Vassy ◽  
Cathelijne H. van der Wouden ◽  
...  
Keyword(s):  
Prescription Medication ◽  
Genomic Testing ◽  
Personal Genomics ◽  
Personal Genomic ◽  
Personal Genomic Testing ◽  
Direct To Consumer ◽  
The Impact ◽  
Medication Changes

scholarly journals Cases in Precision Medicine: When Patients Present With Direct-to-Consumer Genetic Test Results

2019 ◽  
Vol 170 (9) ◽  
pp. 643 ◽  
Author(s):  
Michael G. Artin ◽  
Deborah Stiles ◽  
Krzysztof Kiryluk ◽  
Wendy K. Chung
Keyword(s):  
Precision Medicine ◽  
Genetic Test ◽  
Test Results ◽  
Direct To Consumer ◽  
Genetic Test Results

scholarly journals Consumers report lower confidence in their genetics knowledge following direct-to-consumer personal genomic testing

2015 ◽  
Vol 18 (1) ◽  
pp. 65-72 ◽  
Author(s):  
Deanna Alexis Carere ◽  
◽  
Peter Kraft ◽  
Kimberly A. Kaphingst ◽  
J. Scott Roberts ◽  
...  
Keyword(s):  
Genomic Testing ◽  
Personal Genomic ◽  
Personal Genomic Testing ◽  
Direct To Consumer ◽  
Lower Confidence ◽  
Genetics Knowledge

scholarly journals Genetic testing for Parkinson disease

2020 ◽  
pp. 10.1212/CPJ.0000000000000831
Author(s):  
Lola Cook ◽  
Jeanine Schulze ◽  
Catherine Kopil ◽  
Tara Hastings ◽  
Anna Naito ◽  
...  
Keyword(s):  
Genetic Testing ◽  
Parkinson Disease ◽  
Clinical Utility ◽  
Genetic Test ◽  
Genomic Testing ◽  
Test Results ◽  
Genetic Test Results ◽  
Genetic Status ◽  
Genetic Landscape ◽  
Busy Clinician

Purpose of reviewWith the advent of precision medicine and demand for genomic testing information, we may question whether it is time to offer genetic testing to our patients with Parkinson disease (PD). This review updates the current genetic landscape of PD, describes what genetic testing may offer, provides strategies for evaluating whom to test, and provides resources for the busy clinician.Recent findingsPatients with PD and their relatives, in various settings, have expressed an interest in learning their PD genetic status; however, physicians may be hesitant to widely offer testing due to the perceived low clinical utility of PD genetic test results. The rise of clinical trials available for patients with gene-specific PD and emerging information on genotype-phenotype correlations are starting to shift this discussion about testing.SummaryBy learning more about the various genetic testing options for PD and utility of results for patients and their care, clinicians may become more comfortable with widespread PD genetic testing in the research and clinical setting.

Direct to consumer personal genomic testing and trust

2020 ◽  
pp. 101-129
Author(s):  
Manuel Schaper ◽  
Aviad Raz ◽  
Marie Falahee ◽  
Karim Raza ◽  
Danielle Timmermans ◽  
...  
Keyword(s):  
Genomic Testing ◽  
Personal Genomic ◽  
Personal Genomic Testing ◽  
Direct To Consumer
Sign in / Sign up

Export Citation Format

Share Document